Literature DB >> 12122229

Haemorheological profile in metabolic Syndrome.

R Lo Presti1, D Sinagra, M Montana, A M Scarpitta, A Catania, G Caimi.   

Abstract

Metabolic Syndrome (MetS) has been defined as a clinical condition including impaired glucose tolerance or diabetes mellitus and/or insulin-resistance, associated with two or more of the following components: arterial hypertension, central obesity, dyslipidaemia, microalbuminuria. In a group of subjects with MetS we examined the macrohaemorheological profile, demonstrating a significant increase of blood, plasma and serum viscosity and a decrease of whole blood filterability. The results show that in these subjects a secondary hyperviscosity condition is present, but also that several significant correlations are present between the haemorheological variables and some aspects of MetS, especially those reflecting central obesity (waist to hip ratio) and insulin-resistance. The altered haemorheological profile likely contributes to explain the high cardiovascular risk present in MetS, but it may also participate, through its influence on haemodynamic pattern, in the pathogenesis of insulin-resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122229

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  5 in total

1.  Association of hyperviscosity and subclinical atherosclerosis in obese schoolchildren.

Authors:  Weihua Zhu; Mengxia Li; Xianmei Huang; Henning Neubauer
Journal:  Eur J Pediatr       Date:  2005-07-12       Impact factor: 3.183

2.  Hemorheological disorders in diabetes mellitus.

Authors:  Young I Cho; Michael P Mooney; Daniel J Cho
Journal:  J Diabetes Sci Technol       Date:  2008-11

3.  Dextran induces differentiation of circulating endothelial progenitor cells.

Authors:  Syotaro Obi; Haruchika Masuda; Hiroshi Akimaru; Tomoko Shizuno; Kimiko Yamamoto; Joji Ando; Takayuki Asahara
Journal:  Physiol Rep       Date:  2014-03-20

4.  Blood rheology and platelet function in untreated early-stage essential hypertensives complicated with metabolic syndrome.

Authors:  Hiroko Sugimori; Fumihiro Tomoda; Tsutomu Koike; Hiroyuki Kinuno; Hiroko Kurosaki; Toshitaka Masutani; Hiroshi Inoue
Journal:  Int J Hypertens       Date:  2012-04-18       Impact factor: 2.420

5.  Red Blood Cells from Individuals with Abdominal Obesity or Metabolic Abnormalities Exhibit Less Deformability upon Entering a Constriction.

Authors:  Nancy F Zeng; Jordan E Mancuso; Angela M Zivkovic; Jennifer T Smilowitz; William D Ristenpart
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.